ANDROGENETIC ALOPECIA (AGA)

This study tests an oral drug called VDPHL01 in 552 women aged 18–65 with mild to moderate hereditary hair loss. Participants take a pill once or twice daily for about 13 months. The goal is to see if it increases hair count and if women feel their hair looks better. It's a place…

This study tests an experimental drug called OLX72021 in 158 men with mild to moderate male pattern baldness. The drug is injected into the scalp to see if it can safely increase hair count. The trial is in early phases, so it focuses on safety and how well the drug works.

This study is testing whether combining platelet-rich plasma (PRP) with Botox injections works better than PRP alone for treating androgenetic alopecia (common pattern baldness). About 76 adults aged 18 to 60 with mild to moderate hair loss will receive either the combo treatment…

This study tests if a lotion made with Lactobacillus reuteri, a friendly bacteria, can safely help regrow hair in people with pattern baldness. About 388 adults will use the probiotic lotion, a placebo, or standard minoxidil for 12 months. The goal is to see if balancing scalp ba…

This study compares a new peptide-based hair serum to the standard treatment minoxidil for people with pattern baldness. About 80 adults with mild to moderate hair loss will use one of the two treatments for 24 weeks. Researchers will measure changes in hair density and thickness…

This early-stage study tests a new medication called ABS-201 to see if it is safe and tolerable for improving hair growth. It starts with healthy volunteers and then includes people with a common type of hair loss (androgenetic alopecia). Participants receive either ABS-201 or a …